BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3303010)

  • 1. [Immunohistologic markers in the diagnosis and prognosis of malignant melanomas].
    Suter L; Bröcker EB
    Pathologe; 1987 May; 8(3):163-7. PubMed ID: 3303010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant blue nevus].
    Rupec R; Eckert F; Ruzicka T
    Hautarzt; 1993 Mar; 44(3):164-6. PubMed ID: 8463099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of S 100 protein in malignant melanoma of the skin. Pattern of distribution and significance for determination of tumor thickness].
    Flügge G; Rassner G
    Hautarzt; 1989 May; 40(5):290-5. PubMed ID: 2661501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigmented epithelioid melanocytoma.
    Ward JR; Brady SP; Tada H; Levin NA
    Int J Dermatol; 2006 Dec; 45(12):1403-5. PubMed ID: 17184238
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
    Thies A; Berlin A; Brunner G; Schulze HJ; Moll I; Pfüller U; Wagener C; Schachner M; Altevogt P; Schumacher U
    Cancer Lett; 2007 Apr; 248(1):68-80. PubMed ID: 16822608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial markers in primary sinonasal mucosal melanoma.
    Feeley C; Theaker J
    Histopathology; 2004 Jul; 45(1):96-8. PubMed ID: 15228456
    [No Abstract]   [Full Text] [Related]  

  • 9. Compound nevus with congenital features and balloon cell changes--an immunohistochemical study.
    Cagnano E; Benharroch D; Sion-Vardy N
    Ann Diagn Pathol; 2008 Oct; 12(5):362-4. PubMed ID: 18774500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of neoplastic cells in the lymphocytic infiltrate associated with thin melanomas.
    Salvio AG; Ribeiro DA; Marques ME
    Histopathology; 2007 Jun; 50(7):942-4. PubMed ID: 17543085
    [No Abstract]   [Full Text] [Related]  

  • 12. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
    Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
    Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in malignant choroid melanoma].
    Scheiffarth OF; Strobl J; Stefani FH; Riedel KG; Scheidhauer K
    Fortschr Ophthalmol; 1989; 86(6):639-43. PubMed ID: 2696716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelanotic malignant melanomas of the oral mucosa.
    Notani K; Shindoh M; Yamazaki Y; Nakamura H; Watanabe M; Kogoh T; Ferguson MM; Fukuda H
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):195-200. PubMed ID: 12054708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Generalized melanosis with metastatic melanoma--immunohistologic studies].
    Jung EM; Betke M; Gokel JM
    Pathologe; 1991 Nov; 12(6):343-6. PubMed ID: 1792218
    [No Abstract]   [Full Text] [Related]  

  • 16. Endometrial metastasis of cutaneous melanoma - A case-report bearing diagnostic difficulties -.
    Heinig J; August C; Beckmann V; Konieczny A
    Zentralbl Gynakol; 2001 Sep; 123(9):534-5. PubMed ID: 11709747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.
    Garbe C; Leiter U; Ellwanger U; Blaheta HJ; Meier F; Rassner G; Schittek B
    Cancer; 2003 Apr; 97(7):1737-45. PubMed ID: 12655531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
    Laskin WB; Knittel DR; Frame JN
    Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanoma metastasis in donor site of full-thickness skin graft.
    Serrano-Ortega S; Buendia-Eisman A; Ortega del Olmo RM; Linares Solano J
    Dermatology; 2000; 201(4):377-8. PubMed ID: 11146359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.